Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Cipolla

Showing results (51-60 of 55) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 55 results.
Journal of Aerosol Medicine and Pulmonary Drug Delivery|March 15, 2012
Equivalence considerations for orally inhaled products for local action-ISAM/IPAC-RS European Workshop reportCarole Evans, David Cipolla, Tim Chesworth, et al.
Antimicrobial Agents and Chemotherapy|October 12, 2022
Correction for Plaunt et al., "Development and Preclinical Evaluation of New Inhaled Lipoglycopeptides for the Treatment of Persistent Pulmonary Methicillin-Resistant Staphylococcus aureus Infections"Adam J Plaunt, Sasha J Rose, Jeong Yeon Kang, et al.
Antimicrobial Agents and Chemotherapy|May 4, 2021
Development and Preclinical Evaluation of New Inhaled Lipoglycopeptides for the Treatment of Persistent Pulmonary Methicillin-Resistant Staphylococcus aureus InfectionsAdam J Plaunt, Sasha J Rose, Jeong Yeon Kang, et al.
American Journal of Respiratory and Critical Care Medicine|February 12, 2025
Broad Immunomodulatory Effects of the Dipeptidyl-peptidase-1 Inhibitor Brensocatib in Bronchiectasis: Data from the Phase 2, Double-Blind, Placebo-controlled WILLOW TrialEmma D Johnson, Merete B Long, Lidia Perea, et al.
The Lancet. Respiratory Medicine|April 27, 2026
Azurocidin-1 as a mediator of bronchiectasis severity, epithelial defence, and target of dipeptidyl peptidase-1 inhibition: an international, multicohort studyAmelia Shoemark, Emma D Johnson, Morven Shuttleworth, et al.
Pageof 6

Showing results (51-60 of 55) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 55 results.
Journal of Aerosol Medicine and Pulmonary Drug Delivery|March 15, 2012
Equivalence considerations for orally inhaled products for local action-ISAM/IPAC-RS European Workshop reportCarole Evans, David Cipolla, Tim Chesworth, et al.
Antimicrobial Agents and Chemotherapy|October 12, 2022
Correction for Plaunt et al., "Development and Preclinical Evaluation of New Inhaled Lipoglycopeptides for the Treatment of Persistent Pulmonary Methicillin-Resistant Staphylococcus aureus Infections"Adam J Plaunt, Sasha J Rose, Jeong Yeon Kang, et al.
Antimicrobial Agents and Chemotherapy|May 4, 2021
Development and Preclinical Evaluation of New Inhaled Lipoglycopeptides for the Treatment of Persistent Pulmonary Methicillin-Resistant Staphylococcus aureus InfectionsAdam J Plaunt, Sasha J Rose, Jeong Yeon Kang, et al.
American Journal of Respiratory and Critical Care Medicine|February 12, 2025
Broad Immunomodulatory Effects of the Dipeptidyl-peptidase-1 Inhibitor Brensocatib in Bronchiectasis: Data from the Phase 2, Double-Blind, Placebo-controlled WILLOW TrialEmma D Johnson, Merete B Long, Lidia Perea, et al.
The Lancet. Respiratory Medicine|April 27, 2026
Azurocidin-1 as a mediator of bronchiectasis severity, epithelial defence, and target of dipeptidyl peptidase-1 inhibition: an international, multicohort studyAmelia Shoemark, Emma D Johnson, Morven Shuttleworth, et al.
Pageof 6